In this page, I share my leukemia treatment timeline, documenting the stages and experiences of my journey through Philadelphia-positive Acute Lymphoblastic Leukemia (Ph+ ALL) treatment.
My Leukemia Treatment Timeline: A Personal Journey
CNS Positive for Leukemic Blasts
I received some challenging news: I tested positive for central nervous system (CNS) leukemic blasts. This means that leukemia cells have been found in my cerebrospinal fluid, necessitating a more intensive treatment approach.
To address this, I have had to undergo intrathecal chemotherapy twice a week. This involves administering chemotherapy directly into my cerebrospinal fluid through a lumbar puncture (spinal tap). It’s a rigorous process, but it’s essential for targeting and eliminating these leukemia cells in my CNS.
Measurable Residual Disease Positive
Despite the aggressive treatments I’ve been undergoing, I recently received some tough news. My measurable residual disease (MRD) result came back positive at 28.81% with a sensitivity of 10>3. This means that I still have a significant amount of leukemia cells present in my body. My leukemic blasts having decreased from 53.23% to 28.81%. While this shows some progress, it’s clear that the fight is far from over.
Prednisone, Ponatinib, and Asciminib Combination
My doctors decided to try a new combination of medications: Prednisone, Ponatinib, and Asciminib. They are hopeful that this combination will have a synergistic effect in stopping the growth of my leukemia.
Despite the challenges I’ve faced, including my measurable residual disease (MRD) result of 28.81% and the relapse of Philadelphia Positive B-cell acute lymphoblastic leukemia, I’m optimistic about this new treatment plan.
CNS Negative for Leukemic Blasts
After undergoing intrathecal chemotherapy four times, my central nervous system (CNS) is now negative for leukemic blasts. This is a significant milestone in my treatment journey and brings a sense of relief amidst the challenges.
However, I will still need to go through multiple additional intrathecal chemotherapy sessions to ensure the leukemia stays at bay and to prevent any recurrence.